» Authors » Joana C Silva

Joana C Silva

Explore the profile of Joana C Silva including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 89
Citations 4122
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Mbambo G, Dwivedi A, Ifeonu O, Munro J, Shrestha B, Bromley R, et al.
Front Immunol . 2023 Jul; 14:1179314. PMID: 37465667
Introduction: Host gene and protein expression impact susceptibility to clinical malaria, but the balance of immune cell populations, cytokines and genes that contributes to protection, remains incompletely understood. Little is...
12.
Wichers-Misterek J, Krumkamp R, Held J, von Thien H, Wittmann I, Hoppner Y, et al.
PLoS Pathog . 2023 Jun; 19(6):e1011468. PMID: 37384799
Controlled human malaria infections (CHMI) are a valuable tool to study parasite gene expression in vivo under defined conditions. In previous studies, virulence gene expression was analyzed in samples from...
13.
Molina-Cruz A, Canepa G, Dwivedi A, Liu W, Raytselis N, Antonio-Nkondjio C, et al.
Proc Natl Acad Sci U S A . 2023 Jan; 120(5):e2213626120. PMID: 36689648
malaria originated when , a gorilla malaria parasite transmitted by African sylvan anopheline mosquitoes, adapted to humans. Pfs47, a protein on the parasite surface mediates evasion of the mosquito immune...
14.
Liberles D, Alvarez-Ponce D, Meyer M, Minh B, Silva J
J Mol Evol . 2023 Jan; 91(1):1. PMID: 36609706
No abstract available.
15.
Tavares W, Morais J, Martins J, Scalsky R, Stabler T, Medeiros M, et al.
Malar J . 2022 Dec; 21(1):396. PMID: 36577996
Over the past two decades, a considerable expansion of malaria interventions has occurred at the national level in Angola, together with cross-border initiatives and regional efforts in southern Africa. Currently,...
16.
Moita D, Maia T, Duarte M, Andrade C, Albuquerque I, Dwivedi A, et al.
NPJ Vaccines . 2022 Dec; 7(1):163. PMID: 36526627
Two malaria parasite species, Plasmodium falciparum (Pf) and P. vivax (Pv) are responsible for most of the disease burden caused by malaria. Vaccine development against this disease has focused mainly...
17.
Stabler T, Dwivedi A, Shrestha B, Joshi S, Schindler T, Ouattara A, et al.
Malar J . 2022 Nov; 21(1):357. PMID: 36447234
Background: The ability of malaria rapid diagnostic tests (RDTs) to effectively detect active infections is being compromised by the presence of malaria strains with genomic deletions at the hrp2 and...
18.
Silva J, Seixas E, Anacleto G
Eur J Vasc Endovasc Surg . 2022 Nov; 65(5):764. PMID: 36334904
No abstract available.
19.
Ouattara A, Dwivedi A, Adams M, Niangaly A, Laurens M, Nyunt M, et al.
Microorganisms . 2022 Jun; 10(6). PMID: 35744609
Failure to account for genetic diversity of antigens during vaccine design may lead to vaccine escape. To evaluate the vaccine escape potential of antigens used in vaccines currently in development...
20.
Silva J, Dwivedi A, Moser K, Sissoko M, Epstein J, Healy S, et al.
Nat Commun . 2022 Jun; 13(1):3390. PMID: 35697668
Controlled human malaria infection (CHMI) has supported Plasmodium falciparum (Pf) malaria vaccine development by providing preliminary estimates of vaccine efficacy (VE). Because CHMIs generally use Pf strains similar to vaccine...